P.019 Motor evoked potentials as a new biomarker in multiple sclerosis

Autor: FH Jacques, J Fortin, M Lecompte, V Sikati Foko, E Apedaile

Publikováno v: Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 46:S18

Background: Motor evoked potentials (MEP’S) measure myelin/axonal integrity of the central nervous system. MEP’s reliability and correlation to conventional clinical measures in multiple sclerosis (MS) patients have yet to be demonstrated. Alemtu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f83fb51efa2832081814584f0c58aeb2
https://doi.org/10.1017/cjn.2019.119

Neurology (Multiple Sclerosis)

Autor: Pawel Kalinowski, FH Jacques, B Harel, A Schembri, B Bilodeau, C Paquette

Publikováno v: Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 42:S31-S31

Objectives: The objectives of this study are to understand the impact of natalizumab on cognition beyond two years of therapy and to investigate whether baseline characteristics are predictive of clinical response. Methods: This is a single-center, 2

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::16f57ff777984cf28b7096978a6aff56
https://doi.org/10.1017/cjn.2015.149

Avelumab in newly diagnosed glioblastoma.

Autor: Jacques FH; Clinique Neuro-Outaouais, Gatineau, Quebec, Canada., Nicholas G; Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.; Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada., Lorimer IAJ; Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada.; Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada., Sikati Foko V; Clinique Neuro-Outaouais, Gatineau, Quebec, Canada., Prevost J; Clinique Neuro-Outaouais, Gatineau, Quebec, Canada., Dumais N; Clinique Neuro-Outaouais, Gatineau, Quebec, Canada., Milne K; Deeley Research Centre, BC Cancer, Victoria, British Columbia, Canada., Nelson BH; Deeley Research Centre, BC Cancer, Victoria, British Columbia, Canada.; Department of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia, Canada.; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia,Canada., Woulfe J; Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Ontario, Canada., Jansen G; Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Ontario, Canada., Apedaile BE; Clinique Neuro-Outaouais, Gatineau, Quebec, Canada.

Publikováno v: Neuro-oncology advances [Neurooncol Adv] 2021 Aug 25; Vol. 3 (1), pp. vdab118. Date of Electronic Publication: 2021 Aug 25 (Print Publication: 2021).

Evaluating Soluble EMMPRIN as a Marker of Disease Activity in Multiple Sclerosis: Studies of Serum and Cerebrospinal Fluid.

Autor: Kaushik DK; Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada., Yong HY; Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada., Hahn JN; Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada., Silva C; Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada., Casha S; Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada., Hurlbert RJ; Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada., Jacques FH; CSSSG-Hull Pavilion, Gatineau, Quebec, Canada., Lisak R; Multiple Sclerosis Center, Wayne State University School of Medicine, Detroit, Michigan, United States of America., Khan O; Multiple Sclerosis Center, Wayne State University School of Medicine, Detroit, Michigan, United States of America., Ionete C; Multiple Sclerosis Center, University of Massachusetts, Worcester, Massachusetts, United States of America., Larochelle C; University of Montreal, Montreal, Quebec, Canada., Prat A; University of Montreal, Montreal, Quebec, Canada., Bar-Or A; Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada., Yong VW; Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.

Publikováno v: PloS one [PLoS One] 2016 Oct 11; Vol. 11 (10), pp. e0163802. Date of Electronic Publication: 2016 Oct 11 (Print Publication: 2016).

Defining the clinical course of multiple sclerosis: the 2013 revisions.

Autor: Jacques FH; Gatineau, Canada.

Publikováno v: Neurology [Neurology] 2015 Mar 03; Vol. 84 (9), pp. 963.